Israel's 1998 Budget And Moves To Health Reforms

28 October 1997

In Israel, health is "becoming a macroeconomic issue, and the problemswhich could arise in the health area are of such a size that they require continuous solutions," says David Milgrom, head of the Treasury's Budgets Division.

An additional budget of 500 million shekels ($141.8 million) is intended for updating health care services, including geriatric hospitalization and increased physician and nursing staff.

The Treasury has indicated its desire for changes to the National Health Insurance Law, which, says Mr Milgrom, "creates a lack of efficiency and motivation for the sick funds to balance their budgets. The root of the problem is that on the one hand, the NHIL gives the funds the responsibility to provide the services, but on the other hand, it takes from them, by virtue of almost full 'nationalization,' the crucial degrees of freedom. In this situation the funds show apathy, as they have been turned into subcontractors of the government. The consequence is the creation of deficits which are rolled over to the door of the government."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight